Evolent Health Inc (EVH) is Reiterated by FBR Capital to Outperform, Raises Price Target to $ 26

Evolent Health Inc (EVH) was Reiterated by FBR Capital to “Outperform” according to the research note released today. The brokerage firm has raised the Price Target to $ 26 from a previous price target of $24 . FBR Capital advised their investors in a research report released on Aug 5, 2016.

Many Wall Street Analysts have commented on Evolent Health Inc. Evolent Health Inc was Initiated by Jefferies to “Buy” on Jul 26, 2016. Company shares were Reiterated by FBR Capital on Jul 13, 2016 to “Outperform”, Firm has raised the Price Target to $ 24 from a previous price target of $16 .

On the company’s financial health, Evolent Health Inc reported $-0.20 EPS for the quarter, missing the analyst consensus estimate by $ -0.04 based on the information available during the earnings call on Aug 4, 2016. Analyst had a consensus of $-0.16. The company had revenue of $56.50 million for the quarter, compared to analysts expectations of $51.99 million. The company’s revenue was up 443.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.95 EPS.

Evolent Health Inc closed down -0.27 points or -1.12% at $23.91 with 3,12,934 shares getting traded on Thursday. Post opening the session at $24.26, the shares hit an intraday low of $23.45 and an intraday high of $24.29 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

In a different news, on Jun 10, 2015, Gary Piefer (Chief Medical Officer) purchased 2,000 shares at $17.00 per share price.

Evolent Health Inc. is engaged in the healthcare delivery and payment markets. The Company’s platform enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to value-based payment models. It provides an end-to-end technology-enabled services platform for providers to transition their organization in value-based payment models. It markets and sells services to providers throughout the United States. The Company works with its partners in two phases. In the transformation phase it works with its partners to develop a plan for their transition to a value-based care model. During the second portion of the transformation phase the Company works with its partner to implement the Blueprint. During the transformation phase the Company seeks to enter into long-term agreements with its partners. In the platform and operations phase the Company establishes a local market presence and embeds its resources alongside the Company’s partners.

Evolent Health Inc

Leave a Reply

Evolent Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Evolent Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.